Avricore Health Inc (AVCR) - Total Liabilities

Latest as of March 2026: CA$389.17K CAD ≈ $281.52K USD

Based on the latest financial reports, Avricore Health Inc (AVCR) has total liabilities worth CA$389.17K CAD (≈ $281.52K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Avricore Health Inc (AVCR) asset resilience to evaluate the company's liquid asset resilience ratio.

Avricore Health Inc - Total Liabilities Trend (2000–2025)

This chart illustrates how Avricore Health Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Avricore Health Inc.

Avricore Health Inc Competitors by Total Liabilities

The table below lists competitors of Avricore Health Inc ranked by their total liabilities.

Company Country Total Liabilities
Methanor
PA:ALMET
France €43.46K
MEKICS Co Ltd
KQ:058110
Korea ₩19.37 Billion
NuCana PLC
NASDAQ:NCNA
USA $5.50 Million
Cahaya Bintang Medan Tbk Pt
JK:CBMF
Indonesia Rp117.80 Billion
COLLPLANT BIOTECH. IS-01
F:CPT
Germany €4.30 Million
Anglo Asian Mining Plc
LSE:AAZ
UK GBX84.38 Million
Philly Shipyard ASA
OL:PHLY
Norway Nkr100.00K
Polar Capital Global Healthcare Trust plc
LSE:PCGH
UK GBX40.91 Million

Liability Composition Analysis (2000–2025)

This chart breaks down Avricore Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Avricore Health Inc balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.03 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.99 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.67 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avricore Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avricore Health Inc (2000–2025)

The table below shows the annual total liabilities of Avricore Health Inc from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 CA$173.56K
≈ $125.55K
-47.54%
2024-12-31 CA$330.82K
≈ $239.31K
-37.49%
2023-12-31 CA$529.22K
≈ $382.83K
-12.51%
2022-12-31 CA$604.89K
≈ $437.57K
+616.04%
2021-12-31 CA$84.48K
≈ $61.11K
-92.68%
2020-12-31 CA$1.15 Million
≈ $834.88K
+71.27%
2019-12-31 CA$673.85K
≈ $487.45K
+114.44%
2018-12-31 CA$314.24K
≈ $227.32K
-21.85%
2017-12-31 CA$402.09K
≈ $290.87K
+12.52%
2016-12-31 CA$357.34K
≈ $258.50K
+45.13%
2015-12-31 CA$246.23K
≈ $178.12K
+31.59%
2014-12-31 CA$187.12K
≈ $135.36K
+18.94%
2013-12-31 CA$157.32K
≈ $113.80K
-56.82%
2012-12-31 CA$364.30K
≈ $263.53K
-72.83%
2011-12-31 CA$1.34 Million
≈ $970.00K
+6.68%
2010-12-31 CA$1.26 Million
≈ $909.29K
+12.86%
2009-12-31 CA$1.11 Million
≈ $805.68K
+1881.27%
2008-12-31 CA$56.22K
≈ $40.67K
-2.95%
2007-12-31 CA$57.92K
≈ $41.90K
-22.01%
2006-12-31 CA$74.27K
≈ $53.72K
+24.81%
2005-12-31 CA$59.50K
≈ $43.04K
+99.24%
2004-12-31 CA$29.86K
≈ $21.60K
-2.22%
2003-12-31 CA$30.54K
≈ $22.09K
-70.51%
2002-12-31 CA$103.56K
≈ $74.91K
+1833.89%
2001-12-31 CA$5.36K
≈ $3.87K
+32.78%
2000-12-31 CA$4.03K
≈ $2.92K
--

About Avricore Health Inc

V:AVCR Canada Diagnostics & Research
Market Cap
$5.48 Million
CA$7.58 Million CAD
Market Cap Rank
#28495 Global
#1260 in Canada
Share Price
CA$0.06
Change (1 day)
+0.00%
52-Week Range
CA$0.05 - CA$0.09
All Time High
CA$8.32
About

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to A… Read more